International Clinical Trials Day 2026: How Xcene Research is expanding African medical frontier
L-R: Adeseye Akinsete, consultant paediatric hematologist and oncologist, Lagos University Teaching Hospital (LUTH); Osas Osunde, associate director, Medical Affairs and Trial Management, Xcene Research; Faramola Ogunkoya, associate director, Clinical Operations, Trial Management and Delivery, Xcene Research; Christina Amira, consultant nephrologist, LUTH; and David Oladele, head, Clinical Trial Management Unit, Nigerian Institute of Medical Research (NIMR) during the commemoration of the International Clinical Trials Day 2026
Clinical research is often discussed in cold, sterile terms covering data points, protocols, inclusion gaps, and regulatory frameworks. But for African patient populations, a clinical trial is far more than just science or research. It represents a vital opportunity to plug into global medical innovation, a hope for meaningful contribution, and an active role in a global movement shifting from struggle to solution.
Building on annual efforts to overcome structural barriers across Sub-Saharan Africa, the 2026 International Clinical Trials Day theme, ‘Research Rising’, celebrates the people behind the knowledge just as much as the breakthroughs in molecular research.
At the centre of this shift is Xcene Research. By dismantling deep-seated myths and misconceptions through over a decade of uncompromising safety, ethical compliance, and patient-centric protocol design, Xcene has navigated the Sub-Saharan healthcare landscape with unmatched local expertise and global impact. Through this journey, the company has learned that the most vital ingredient in any study is not the protocol itself, but trust.
For too long, the narrative of clinical trials in Africa has been shadowed by historical skepticism. To dismantle these barriers and truly realize the potential of ‘Research Rising’, Xcene is building trust through transparency, delivering clear, direct information to the communities most affected: current participants and those seeking to enroll.
From individuals seeking innovative treatments for cancer, rare conditions, and sickle cell disease, to those receiving life-saving vaccinations, clinical research ultimately touches us all. The organisation’s ecosystem of scientists, clinicians, regulatory agencies, research institutions, and purpose-driven sponsors depends on the proliferation of these trials to deliver the diagnostics and personalized treatments that improve not just African, but global patient outcomes.
To mark this year’s commemoration, Xcene Research engaged clinical trial stakeholders at the Nigerian Institute of Medical Research (NIMR), Yaba, Lagos. This gathering was more than just celebrating a date on the calendar. It was a tribute to all past and intending study participants in the fight of human biology. The participants included the tireless clinical research professionals such as principal investigators, scientists, CRAs and review boards who ensure African data is represented in global health solutions.
“We are shifting the narrative from ‘what if’ to ‘what is’,” said Faramola Ogunkoya, Associate Director of Clinical Operations, Trial Management, and Delivery at Xcene Research. “Clinical trials are the engine turning moments of despair into milestones of hope for the future of medicine. When research rises, we all rise, delivering a brighter, healthier future for generations to come.”
Also speaking at the event, David Oladele, head, Clinical Trial Management Unit, Nigerian Institute of Medical Research, (NIMR) who also represented the director general of NIMR, noted that clinical trials are key to improving medicine access in Africa, which will also increase health investments and strengthen infrastructural gaps.
Why Africa?
The impact of clinical trials goes beyond individual treatments. It is about healthcare sovereignty and a healthier population to drive growth on the continent, according to Xcene Research. By conducting trials within African borders, the research group believes that treatments are primarily optimised for Africans’ unique genetic diversity.
Furthermore, local healthcare infrastructures are strengthened through high-standard research sites, enabling the continent’s transition from mere consumers of global medicine into active contributors to medical innovation.
Xcene Research is a leading Contract Research Organization (CRO) dedicated to transforming the clinical trial landscape in Sub-Saharan Africa.
Through a commitment to Diversity, Equity, and Inclusion (DEI), Xcene Research works at the intersection of local expertise and global impact.
